Category: Covidien
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Covidien lands 510(k) clearance for its Nellcor bedside respiratory patient monitoring system, which aims to reduce costs and service disruptions.
Medical device company Covidien (NYSE:COV) landed FDA 510(k) clearance and European CE Mark approval for the Nellcor bedside respiratory patient monitoring system, which will help clinicians detect and respond to dangerous respiratory events sooner, the company said.
A federal judge awards AngioDynamics nearly $17 million in damages in a breach of contract lawsuit filed against the German medical laser maker.
Tyco International, forebear of medical device industry titan Covidien, settles a federal bribery probe for $26 million after investigators find that Tyco Healthcare used illegal payments to influence doctors and public health professionals in Saudi Arabia, China and Poland.
Security giant Tyco International (NYSE:TYC), father of medical device company Covidien (NYSE:COV), agreed to pay a $26 million settlement to close the books on an international bribery scandal that involved health officials in Saudi Arabia, China and Poland.
U.K. health regulators updated an ongoing recall of medical device company Covidien's potentially leaky breathing tubes.
The U.K.'s Medicines & Healthcare products Regulatory Agency issued a new alert on an ongoing recall of Covidien's (NYSE:COV) cuffed Shiley tracheostomy tubes, urging healthcare providers to identify and quarantine the devices as soon as possible.
Cost-cutting moves by medical device companies have resulted in the loss of more than 2,000 jobs over the past 2 months.
Medical device companies are molting at a reptilian rate, shedding more than 2,000 jobs over the past 2 months as they look to slash costs across the board.
Several of the med-tech companies that are scrapping jobs say the 2.3% medical device excise tax in the Patient Protection and Affordable Care Act, slated to begin in January 2013. Others deny that the tax is the sole cause of their moves, saying it's a factor but not determinative.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
